Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...

0
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....

0
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...

Popular News

MAKE IT MODERN

LATEST REVIEWS

Atara Biotherapeutics Inc (NASDAQ:ATRA) Reveals That Underwriters Have Exercised Option To...

0
Atara Biotherapeutics Inc (NASDAQ:ATRA) recently announced that its underwriters have exercised their option to purchase an extra 2,325,000 shares after closing the initial purchase. Atara...

MAKE IT MODERN

PERFORMANCE TRAINING

Investing in Emerging Ad Tech Opportunities (PUBM, CRTO, CMGR, MGNI)

0
The Ad industry is rapidly evolving before our eyes. But evolution is nothing new to this space. It has always been in...

The Telehealth Revolution Readies for the Spotlight (LVGO, NXGN, RXMD, TDOC)

0
We’re never going back. The world, as it existed six months ago in the pre-pandemic reality, is gone. Forever. It’s not a temporary shift....

CRISPR Therapeutics (NASDAQ: CRSP) Provided Updated Data From Study Evaluating CTX110 in r/r CD19+...

0
CRISPR Therapeutics (NASDAQ: CRSP) has announced updated data from its ongoing Phase 1 CARBON study evaluating CTX110’s efficacy and safety in refractory or relapsed...

Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Receives Funding To Advance HIV Therapy Through ProNeura Platform...

0
Titan Pharmaceuticals Inc. (NASDAQ: TTNP) has received financing from the Bill and Melinda Gates Foundation supporting the demonstration of its capability to produce a...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Submits Clinical Study Data For...

0
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have submitted clinical study data for their COVID019 vaccine to the FDA  for children 5-11...

MAKE IT MODERN

POPULAR